SYY
41
2
NWS
75
6
DIS
72
4
STT
64
5
IVZ
48
3
NFLX
74
4
SNA
58
2
MCO
73
5
CME
61
2
GT
47
4
VLO
28
2
KMB
31
3
EOG
32
3
C
54
4
GD
44
2
AMZN
63
5
ZION
52
3
FOXA
69
5
PNC
49
3
A
47
4
SYY
41
2
NWS
75
6
DIS
72
4
STT
64
5
IVZ
48
3
NFLX
74
4
SNA
58
2
MCO
73
5
CME
61
2
GT
47
4
VLO
28
2
KMB
31
3
EOG
32
3
C
54
4
GD
44
2
AMZN
63
5
ZION
52
3
FOXA
69
5
PNC
49
3
A
47
4
Financhill
Back

Voyager Therapeutics 10K Form

Sell
36

VYGR
Voyager Therapeutics

Last Price:
$5.77
Seasonality Move:
19.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VYGR News And Ratings

See the #1 stock for the next 7 days that we like better than VYGR

VYGR Financial Statistics

Sales & Book Value

Annual Sales: $250M
Cash Flow: $-28.2M
Price / Cash Flow: 44.4
Annual Sales: $6.06
Price / Book: 0.96

Profitability

EPS (TTM): 0.65000
Net Income (TTM): $25.9M
Gross Margin: --
Return on Equity: 9.12%
Return on Assets: 6.54%

Voyager Therapeutics Earnings Forecast

Key Voyager Therapeutics Financial Ratios

  • The Research & Development expenses have been 36.87% of Revenue.
  • The Net Earning history of VYGR is 52.93% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 5 years.

Voyager Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VYGR
CUSIP: 92915B
Website: voyagertherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.45
Quick Ratio: 8.26

Price-to-Earnings

Trailing P/E Ratio: 1.95
Forward P/E Ratio: 0

VYGR Technical Analysis vs Fundamental Analysis

Sell
36
Voyager Therapeutics (VYGR) is a Sell

Is Voyager Therapeutics a Buy or a Sell?